LeadIQ logo
Learn more at LeadIQ.com

Insights

Gene Therapy Innovation Orchard Therapeutics is a global leader in gene therapy with a focus on developing treatments utilizing hematopoietic stem cell gene therapy. This innovative approach offers a unique opportunity for collaboration in the rapidly evolving biotechnology space.

Financial Strength With a significant funding amount of $461M and a revenue range of $10M - $50M, Orchard Therapeutics showcases financial stability and growth potential. This indicates a robust position to engage in strategic partnerships or sales agreements.

Global Expansion Located in London, United Kingdom, Orchard Therapeutics has a global presence that provides access to diverse markets. Leveraging their expanding reach can lead to international sales opportunities and partnerships with a wider network of stakeholders.

Cutting-edge Technology Stack Orchard Therapeutics utilizes a tech stack including Drupal, Cloudflare, and Shopify, reflecting a commitment to leveraging modern technologies. This technological advantage can be highlighted to prospective clients seeking innovative solutions in the biotechnology sector.

Competitive Positioning Among similar companies like CRISPR Therapeutics and Editas Medicine, Orchard Therapeutics stands out with its focused approach on gene therapy. Demonstrating how Orchard's offerings are distinct can attract customers looking for specialized and effective treatments.

Orchard Therapeutics - U.S. Tech Stack

Orchard Therapeutics - U.S. uses 8 technology products and services including Drupal, Cloudflare, Shopify, and more. Explore Orchard Therapeutics - U.S.'s tech stack below.

  • Drupal
    Content Management System
  • Cloudflare
    Content Management System
  • Shopify
    E-commerce
  • jQuery
    Javascript Libraries
  • Babel
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Acquia Cloud Platform
    Platform As A Service
  • Adobe Tag Manager
    Tag Management

Media & News

Orchard Therapeutics - U.S.'s Email Address Formats

Orchard Therapeutics - U.S. uses at least 1 format(s):
Orchard Therapeutics - U.S. Email FormatsExamplePercentage
First.Last@orchard-tx.comJohn.Doe@orchard-tx.com
94%
Last_First@orchard-tx.comDoe_John@orchard-tx.com
3%
Last.F@orchard-tx.comDoe.J@orchard-tx.com
1%
LastF@orchard-tx.comDoeJ@orchard-tx.com
2%

Frequently Asked Questions

Where is Orchard Therapeutics - U.S.'s headquarters located?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s main headquarters is located at 245 Hammersmith Road 3rd Floor London, United Kingdom W6 8PW GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Orchard Therapeutics - U.S.'s phone number?

Minus sign iconPlus sign icon You can contact Orchard Therapeutics - U.S.'s main corporate office by phone at
+1-650-353-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orchard Therapeutics - U.S.'s stock symbol?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. is a publicly traded company; the company's stock symbol is ORTX.

What is Orchard Therapeutics - U.S.'s official website and social media links?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s official website is orchard-tx.com and has social profiles on LinkedIn.

How much revenue does Orchard Therapeutics - U.S. generate?

Minus sign iconPlus sign icon As of December 2024, Orchard Therapeutics - U.S.'s annual revenue reached $35M.

What is Orchard Therapeutics - U.S.'s SIC code NAICS code?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orchard Therapeutics - U.S. have currently?

Minus sign iconPlus sign iconAs of December 2024, Orchard Therapeutics - U.S. has approximately 224 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: B. G.Chief Medical Officer: L. M.Chief Technical Officer: N. L.. Explore Orchard Therapeutics - U.S.'s employee directory with LeadIQ.

What industry does Orchard Therapeutics - U.S. belong to?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. operates in the Biotechnology Research industry.

What technology does Orchard Therapeutics - U.S. use?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s tech stack includes DrupalCloudflareShopifyjQueryBabelOpen GraphAcquia Cloud PlatformAdobe Tag Manager.

What is Orchard Therapeutics - U.S.'s email format?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S.'s email format typically follows the pattern of . Find more Orchard Therapeutics - U.S. email formats with LeadIQ.

How much funding has Orchard Therapeutics - U.S. raised to date?

Minus sign iconPlus sign icon As of December 2024, Orchard Therapeutics - U.S. has raised $461M in funding. The last funding round occurred on Aug 13, 2018 for $150M.

When was Orchard Therapeutics - U.S. founded?

Minus sign iconPlus sign iconOrchard Therapeutics - U.S. was founded in 2015.
Orchard Therapeutics - U.S.

Orchard Therapeutics - U.S.

Biotechnology ResearchUnited Kingdom, United Kingdom201-500 Employees

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment.

Founded in 2015, Orchard’s roots go back to some of the first research and clinical developments involving HSC gene therapy. Our team has played a central role in the evolution of this technology from a promising scientific idea to a potentially life-transforming reality. Today, Orchard is advancing a pipeline of HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist.

For more information, please visit www.orchard-tx.com.

Section iconCompany Overview

Headquarters
245 Hammersmith Road 3rd Floor London, United Kingdom W6 8PW GB
Phone number
+1-650-353-****
Website
orchard-tx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ORTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $461M

    Orchard Therapeutics - U.S. has raised a total of $461M of funding over 4 rounds. Their latest funding round was raised on Aug 13, 2018 in the amount of $150Mas a Series C.

  • $10M$50M

    Orchard Therapeutics - U.S.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $461M

    Orchard Therapeutics - U.S. has raised a total of $461M of funding over 4 rounds. Their latest funding round was raised on Aug 13, 2018 in the amount of $150Mas a Series C.

  • $10M$50M

    Orchard Therapeutics - U.S.'s revenue is in the range of $10M$50M

Company Leadership

  • Stylized image of a person
    B. G.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. M.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. L.
    Chief Technical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Chief Human Resources Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. M.
    Chief Scientific Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. S.
    General Manager Benelux & Emea Partner Markets
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. T.
    President And Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. M.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Chief Human Resources Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. O.
    Regional Manager D-A-Ch, Gentherapie, Orphan Drug, Rare Diseases
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.